在使用detaurlimab治疗子宫内膜癌后的牛皮和牛皮性关节炎
Anurag Ratan Goel1, Charity Sylvester2, Olivia Rose Avidan3
1Departments of Internal Medicine and Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA agoel1@lifespan.org.
BMJ case reports
|August 3, 2024
概括
免疫检查点抑制剂 (ICI) 可以引起与免疫相关的不良事件 (irAEs). 这份病例报告详细介绍了一名患者在为子宫内膜癌治疗达尔巴利马布后患上了牛皮和牛皮性关节炎 (PsA).
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要,但可以引发与免疫相关的不良事件 (irAEs).
- 牛皮和牛皮性关节炎 (PsA) 并不是常见的报道与 dostarlimab,一个特定的ICI相关的irAEs.
- 了解IRE的频谱对于患者管理至关重要.
研究的目的:
- 报告一种罕见的牛皮和牛皮性关节炎 (PsA) 病例,该病例是在 dostarlimab 治疗后发生的.
- 突出皮肤IRAE的表型异质性.
- 审查目前在ICI治疗的背景下管理IREs的指南.
主要方法:
- 一个患有子宫内膜癌的病人用 dostarlimab 接受治疗的案例介绍.
- 临床诊断的重叠的棕植物性状牛皮,斑块牛皮,和PsA.
- 审查三个专业协会的指导方针,用于irAE管理.
主要成果:
- 患者在服用duralimab后出现了显著的皮肤和类风湿症状.
- 治疗包括ICI停药,局部类固醇,口服甲基普雷迪尼索隆和甲铁.
- 指导方针强调严重程度分级,早期使用皮质类固醇,以及对irAEs的类固醇节约剂.
结论:
- 多斯塔利马布可以诱导牛皮和PsA,说明不同的irAE表现.
- 多学科的护理对于管理复杂的IRAEs至关重要.
- 目前的irAE管理指南要求对ICI特异性毒性进行进一步的研究和潜在的适应.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
966
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124


